Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$34.7M Buy
95,907
+14,823
+18% +$5.07M 0.18% 97
2026
Q1
$28.5M Buy
+81,084
New +$28.9M 0.18% 104
2025
Q4
Sell
-57,263
Closed -$16.2M 1037
2025
Q3
$16.2M Sell
57,263
-45,635
-44% -$13.2M 0.16% 121
2025
Q2
$28.7M Buy
102,898
+21,741
+27% +$6.16M 0.33% 51
2025
Q1
$25.3M Sell
81,157
-7,929
-9% -$2.34M 0.36% 38
2024
Q4
$23.2M Buy
89,086
+25,389
+40% +$7.53M 0.34% 36
2024
Q3
$20.5M Sell
63,697
-846
-1% -$277K 0.32% 38
2024
Q2
$20.2M Buy
64,543
+32,150
+99% +$9.44M 0.35% 37
2024
Q1
$9.21M Sell
32,393
-7,185
-18% -$2.1M 0.17% 140
2023
Q4
$11.4M Buy
39,578
+16,497
+71% +$4.49M 0.29% 47
2023
Q3
$6.2M Buy
23,081
+18,665
+423% +$4.66M 0.18% 121
2023
Q2
$980K Sell
4,416
-3,522
-44% -$817K 0.03% 616
2023
Q1
$1.92M Buy
7,938
+1,663
+27% +$408K 0.11% 211
2022
Q4
$1.65M Buy
6,275
+1,703
+37% +$457K 0.11% 201
2022
Q3
$1.03M Buy
4,572
+1,085
+31% +$263K 0.1% 166
2022
Q2
$848K Buy
3,487
+23
+0.7% +$5.64K 0.11% 189
2022
Q1
$838K Buy
3,464
+433
+14% +$99.5K 0.09% 200
2021
Q4
$682K Buy
3,031
+729
+32% +$154K 0.08% 202
2021
Q3
$489K Buy
2,302
+1,014
+79% +$233K 0.06% 181
2021
Q2
$314K Buy
+1,288
New +$317K 0.04% 208

Other funds holding AMGN

Empowered Funds's AMGN Position: Q2 2026 in Review

Empowered Funds increased its Amgen (AMGN) stake by 18% in Q2 2026, buying an estimated $5.07M and bringing the position to 95,907 shares worth $34.7M. The position accounts for 0.18% of the portfolio, ranked #97.

Empowered Funds first reported a position in AMGN in Q2 2021 and has held it in 20 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Empowered Funds held 95,907 shares of Amgen worth $34.7M as of Q2 2026.
  • Empowered Funds bought 14,823 Amgen shares in Q2 2026, an estimated $5.07M.
  • Amgen made up 0.18% of Empowered Funds's portfolio in Q2 2026, its #97 holding.
  • Empowered Funds first reported a position in Amgen in Q2 2021 and has held it in 20 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.